Levothyroxine Sodium Tablet
Product Images NDC 51655-985

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-985). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image-1 (449d2ef9 3580 46c8 8fe5 5d81cb18e40f 01)

Image-1 (449d2ef9 3580 46c8 8fe5 5d81cb18e40f 01)
Chemical structure of Levothyroxine Sodium, showing its molecular composition including sodium ion, iodine atoms, hydroxyl groups, amino acid side chain, and water of hydration.*
FDA Label Image

Label (51655 985 52 Master Bottle Label Approval Rev A 05 22)

Label (51655 985 52 Master Bottle Label Approval Rev A 05 22)
Label for Levothyroxine Sodium Tablets, USP 25 mcg (0.025 mg), 30 count oral tablets by Northwind Health Company, LLC. The label shows prescription-only status, storage instructions at 25°C with permitted excursions, and safeguarding directions against light and moisture. It includes NDC 51655-985-52 and references dosage per package insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.